University of Michigan Rogel Cancer Center: Histotripsy Liver Tumor Trial Successful, Early Clinical Adoption Recommended
October 03, 2024
October 03, 2024
ANN ARBOR, Michigan, Oct. 3 (TNSres) -- The University of Michigan Rogel Cancer Center issued the following news release:
* * *
Used as a local treatment method for liver tumors, the procedure had a 95% success rate
* * *
The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety.
The result, published in Radiology, suppor . . .
* * *
Used as a local treatment method for liver tumors, the procedure had a 95% success rate
* * *
The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety.
The result, published in Radiology, suppor . . .